Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Actemra – Biological Therapy for Rheumatoid Arthritis

Biopharmaceutical production at Roche. Actemra was first deployed in Japan when Chugai (part of the Roche Group) filed for approval for its use as a treatment for rheumatoid arthritis in adult patients and for children with SJIA.



  • Roche Pharmaceutical - R&D Facility
  • Biopharmaceutical Production at Roche
  • Roche's MabThera - Rituxan
  • Actemra - Therapeutic Monoclonal Antibody
  • Roche's MabThera - Rituxan is an Anti-CD20 Monoclonal Antibody

Go Top